Stroke Trials in Minneapolis, United States
Conditions / Stroke / Minneapolis, United States
Research into Stroke spans multiple therapeutic approaches and trial phases.
59 total trials for this combination
Showing top 10 of 59 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01468701 | GLORIA-AF Registry Program - Second and Third Phases | COMPLETED | — |
| NCT00279981 | TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics | COMPLETED | — |
| NCT07224347 | Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT) | ACTIVE_NOT_RECRUITING | — |
| NCT01225562 | Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin | COMPLETED | PHASE3 |
| NCT01038583 | Aspirin in Reducing Events in the Elderly | UNKNOWN | — |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00153062 | PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes | COMPLETED | PHASE4 |
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT02239120 | Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) | COMPLETED | PHASE3 |